Internal Medicine, Hematology & Oncology · Port St Lucie, FL
NPI
1154360642
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1871 SE Tiffany Ave, Suite 100
Port St Lucie, FL, 34952
Phone (772) 335-5666
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.6M
331,938 services
Medicare patients, 2024
1,311
Average age 77
Drug cost, 2024
$8.1M
2,770 prescriptions
Company payments, 2025
$349
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas O Iannotti was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 44,370 times for 49 patients. In total Nicholas O Iannotti billed 331,938 services in 166 codes, and Medicare paid $5.6M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 44,370 | 49 | $0.28 | $12K |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 40,260 | 36 | $0.38 | $15K |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 24,360 | 18 | $0.22 | $5,310 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 21,200 | 23 | $43.27 | $917K |
| J0897 Injection, denosumab, 1 mg | Office | 15,060 | 32 | $20.46 | $308K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 7,890 | 32 | $5.82 | $46K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 6,000 | 39 | $0.09 | $550 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 4,239 | 74 | $0.22 | $949 |
| 85025 Blood Count | Office | 3,722 | 946 | $7.57 | $28K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,628 | 48 | $0.09 | $328 |
| J1576 Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 3,010 | 13 | $52.09 | $157K |
| 36415 Venipuncture Blood Collection | Office | 2,767 | 873 | $8.64 | $24K |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 2,426 | 12 | $32.01 | $78K |
| 80053 Clinical Chemistry | Office | 2,244 | 750 | $10.34 | $23K |
| 99213 Office E&M - Established | Office | 2,085 | 686 | $69.05 | $144K |
By year: 2022 $4.8M for 363,039 services; 2023 $4.6M for 309,008 services; 2024 $5.6M for 331,938 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 3,722 | 946 | $7.57 | $28K |
| 36415 Venipuncture Blood Collection | 2,767 | 873 | $8.64 | $24K |
| 80053 Clinical Chemistry | 2,244 | 750 | $10.34 | $23K |
| 82378 Clinical Chemistry | 881 | 344 | $18.58 | $16K |
| 86300 Immunoassay | 571 | 246 | $20.39 | $12K |
| 82728 Clinical Chemistry | 494 | 250 | $13.33 | $6,586 |
| 83540 Clinical Chemistry | 492 | 248 | $6.33 | $3,113 |
| 83550 Clinical Chemistry | 492 | 248 | $8.55 | $4,208 |
| 83615 Clinical Chemistry | 356 | 129 | $5.92 | $2,108 |
| 82607 Clinical Chemistry | 277 | 200 | $14.73 | $4,079 |
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas O Iannotti prescribed most often to Medicare patients was Anastrozole, with 272 prescriptions and refills. In total Nicholas O Iannotti wrote 2,770 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 272 | 651 | 72 | $4,577 |
| Letrozole Generic | 147 | 361 | 36 | $2,875 |
| Imbruvica Ibrutinib | 140 | 143 | 14 | $2.1M |
| Oxycodone Hcl Generic | 123 | 123 | 55 | $1,947 |
| Aprepitant Generic | 94 | 94 | 21 | $32K |
| Tramadol Hcl Generic | 88 | 88 | 41 | $394 |
| Dexamethasone Generic | 85 | 92 | 27 | $853 |
| Ondansetron Hcl Generic | 80 | 80 | 49 | $836 |
| Hydroxyurea Generic | 76 | 116 | 14 | $1,012 |
| Xtandi Enzalutamide | 70 | 70 | 13 | $976K |
| Prednisone Generic | 60 | 78 | 26 | $396 |
| Prochlorperazine Maleate Generic | 60 | 60 | 33 | $687 |
| Eliquis Apixaban | 57 | 69 | Under 11 | $37K |
| Anagrelide Hcl Generic | 54 | 72 | Under 11 | $6,858 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 50 | 50 | 36 | $749 |
Brand drugs: 743 claims; generic drugs: 2,027 claims; opioid claims: 328.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas O Iannotti $349 ($349 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $177.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.